Search results :

Colesevelam

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C10AC04

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Flatulence Flatulence 12% 14% x x x x
Constipation Constipation 6.5% - 11% 1.96% - 7% x x x x x x x
Infection Infection 10% 13% x x x
Dyspepsia Dyspepsia 2.76% - 8.3% 0.99% - 3.49% x x x x x x x
Headache Headache common, 3.88% - 7.6% 3.08% - 8% x x x x x x x
Nasopharyngitis Nasopharyngitis 4.06% - 6.2% 3.56% - 4.62% x x x
Abdominal pain Abdominal pain 5% 5% x x x x x x x
Gastrointestinal pain Abdominal pain 5% 5% x x x x x x x
Diarrhoea Diarrhoea 5% 7% x x x x
Pain Pain 5% 7% x x x
Blood triglycerides increased Serum triglycerides increased common x
Hypertriglyceridaemia postmarketing x x x
Upper respiratory tract infection Upper respiratory tract infection 4.9% x x x
Asthenia Asthenia 3.59% - 4% 1.94% - 2% x x x x x x
Fatigue 3.88% 1.54% x x x
Nausea Nausea 2.56% - 4.21% 1.42% - 4% x x x x x x x
Injury Accidental injury 3.72% - 4% 2.71% - 3% x x x x x x
Fatigue Fatigue 3.88% 1.54% x x x
Hypoglycaemia Hypoglycaemia 3% - 3.45% 2.31% - 3.07% x x x
Influenza Influenza 3% - 3.8% 3% - 3.1% x x x x x x
Back pain Back pain 2.27% - 3% 1.29% - 6% x x x x
Pharyngitis Pharyngitis 3% - 3.22% 1.94% - 2% x x x x x x
Rhinitis Rhinitis 2.33% - 3.22% 0% - 3.1% x x x x x x
Hypertension Hypertension 2.56% - 2.83% 1.6% - 1.88% x x x
Vomiting Vomiting 2.33% 1.54% x x x x
Sinusitis Sinusitis 2% 4% x x x
Myalgia Myalgia 2% - 2.11% 0% - 0.388% x x x x x x x
Musculoskeletal discomfort Myalgia 2% - 2.11% 0% - 0.388% x x x x x x x
Cough Cough increased 2% 2% x x x
Abdominal distension Abdominal distension postmarketing x x x x
Dysphagia Dysphagia postmarketing, uncommon x x x x
Faecalith Faecalith postmarketing x x x
Faecaloma Faecalith postmarketing x x x
Haemorrhoids Haemorrhoids postmarketing x x x
Hypertriglyceridaemia Hypertriglyceridaemia postmarketing x x x
Intestinal obstruction Intestinal obstruction postmarketing x x x
Pancreatitis Pancreatitis very rare, postmarketing x x x x
Convulsion Convulsion postmarketing x x x
Oesophageal obstruction Oesophageal obstruction postmarketing x x x
Transaminases increased Transaminases increased postmarketing x x x x
Drug interaction Drug interaction postmarketing x x x
Pancreatitis acute Pancreatitis acute x x x
Aortic valve stenosis Aortic valve stenosis x x x
Blister Blister x x x
Dermatitis bullous Blister x x x
Connective tissue disorder Connective tissue disorder x
Dermatitis Rash x x x
Rash Rash x x x
Gastrointestinal disorder Gastrointestinal disorder x
Hypersensitivity Hypersensitivity x x x
Myocardial infarction Myocardial infarction x x x
Acute coronary syndrome Myocardial infarction x x x
Nervous system disorder Nervous system disorder x
Abnormal faeces Abnormal faeces x
Diabetes mellitus Diabetic x x
Bradycardia Bradycardia x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

colesevelam / colesevelam

Side effects:18
Source:EMA

COLESEVELAM HYDROCHLORIDE / WELCHOL

Side effects:18
Source:FDA

COLESEVELAM HYDROCHLORIDE / WELCHOL

Side effects:18
Source:FDA

COLESEVELAM HYDROCHLORIDE / WELCHOL

Side effects:18
Source:FDA

COLESEVELAM

Side effects:36
Source:FDA Structured Product Label

COLESEVELAM

Side effects:36
Source:FDA Structured Product Label

COLESEVELAM

Side effects:36
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label